ATE105476T1 - Dihydropyridin-verbindung zur verbesserung der adernausdehnung und hemmung der herzhypertrophie. - Google Patents

Dihydropyridin-verbindung zur verbesserung der adernausdehnung und hemmung der herzhypertrophie.

Info

Publication number
ATE105476T1
ATE105476T1 AT8888121280T AT88121280T ATE105476T1 AT E105476 T1 ATE105476 T1 AT E105476T1 AT 8888121280 T AT8888121280 T AT 8888121280T AT 88121280 T AT88121280 T AT 88121280T AT E105476 T1 ATE105476 T1 AT E105476T1
Authority
AT
Austria
Prior art keywords
compound
cardiac hypertrophy
venetic
dilonation
dihydropyridin
Prior art date
Application number
AT8888121280T
Other languages
English (en)
Inventor
Takaharu Ono
Minoru Otsuka
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Application granted granted Critical
Publication of ATE105476T1 publication Critical patent/ATE105476T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
AT8888121280T 1987-12-29 1988-12-20 Dihydropyridin-verbindung zur verbesserung der adernausdehnung und hemmung der herzhypertrophie. ATE105476T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33558187 1987-12-29
EP88121280A EP0323604B1 (de) 1987-12-29 1988-12-20 Dihydropyridin-Verbindung zur Verbesserung der Adernausdehnung und Hemmung der Herzhypertrophie

Publications (1)

Publication Number Publication Date
ATE105476T1 true ATE105476T1 (de) 1994-05-15

Family

ID=18290181

Family Applications (1)

Application Number Title Priority Date Filing Date
AT8888121280T ATE105476T1 (de) 1987-12-29 1988-12-20 Dihydropyridin-verbindung zur verbesserung der adernausdehnung und hemmung der herzhypertrophie.

Country Status (6)

Country Link
US (1) US5032601A (de)
EP (1) EP0323604B1 (de)
KR (1) KR970009076B1 (de)
AT (1) ATE105476T1 (de)
CA (1) CA1318596C (de)
DE (1) DE3889532T2 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258393A (en) * 1990-02-21 1993-11-02 Fujisawa Pharmaceutical Co., Ltd. Use of a dihydropyridine compound for improving inner ear microcirculation
ATE132748T1 (de) * 1990-02-21 1996-01-15 Fujisawa Pharmaceutical Co Verwendung eines dihydropyridins zur verbesserung der blutzirkulation des inneren ohres

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338322A (en) * 1975-07-02 1982-07-06 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, pharmaceutical compositions containing same and methods of effecting vasodilation using same
US4284634A (en) * 1975-07-02 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 1,4-Dihydropyridine derivatives, and pharmaceutical method of the same
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same
US4782070A (en) * 1986-07-01 1988-11-01 Fujisawa Pharmaceutical Co., Ltd. Cerebral dysfunction therapeutic agent, which comprises a dihydropyridine compound

Also Published As

Publication number Publication date
DE3889532D1 (de) 1994-06-16
EP0323604A2 (de) 1989-07-12
CA1318596C (en) 1993-06-01
EP0323604B1 (de) 1994-05-11
KR900009076A (ko) 1990-07-02
EP0323604A3 (de) 1991-07-31
DE3889532T2 (de) 1994-08-25
US5032601A (en) 1991-07-16
KR970009076B1 (ko) 1997-06-05

Similar Documents

Publication Publication Date Title
ES2045109T3 (es) 1-fenil-3-naftaleniloxipropanaminas.
NO166938C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenoxyeddiksyrederivater.
DE3462894D1 (de) 3-indolecarboxamide compounds
NO881407L (no) Fremstilling av et soevnfremmende middel.
ES8707959A1 (es) Procedimiento para la obtencion de dihidropiridinas
ATE105476T1 (de) Dihydropyridin-verbindung zur verbesserung der adernausdehnung und hemmung der herzhypertrophie.
ATE38982T1 (de) Guanidinmethylcyclohexancarbonsaeure-derivate, verfahren zur herstellung und pharmazeutische mittel.
ATE86117T1 (de) Zusammensetzung gegen leberkrankheiten.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
DE3884878T2 (de) Uricosuretische Zusammensetzung.
EP0322747A3 (de) Gehirn-Neuron schützendes Mittel, enthaltend eine Dihydropyridin-Verbindung
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.